We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+16.2%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$6.6B
AUM Growth
+$430M
Cap. Flow
+$25.1M
Cap. Flow %
0.38%
Top 10 Hldgs %
17.96%
Holding
434
New
82
Increased
115
Reduced
129
Closed
91

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$48.2M
2
AXNX
Axonics, Inc. Common Stock
AXNX
+$44.8M
3
WING icon
Wingstop
WING
+$42.6M
4
EPAM icon
EPAM Systems
EPAM
+$40M
5
RBA icon
RB Global
RBA
+$38.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$75.3M
2
FIVN icon
FIVE9
FIVN
+$40.4M
3
AIR icon
AAR Corp
AIR
+$34.3M
4
DOCN icon
DigitalOcean
DOCN
+$32.2M
5
XPEV icon
XPeng
XPEV
+$30.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.47%
2 Technology 20.32%
3 Industrials 15.76%
4 Consumer Discretionary 10.97%
5 Consumer Staples 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BILL icon
276
BILL Holdings
BILL
$4.7B
$4.58M 0.07%
34,580
-81,458
-70% -$11.7M
WNC icon
277
Wabash National
WNC
$508M
$4.53M 0.07%
+291,202
New +$4.75M
EQRX
278
DELISTED
EQRx, Inc. Common Stock
EQRX
$4.43M 0.07%
894,749
– –
SLGC
279
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$4.35M 0.07%
1,500,584
-10,761
-0.7% -$45.3K
LSCC icon
280
Lattice Semiconductor
LSCC
$18B
$4.33M 0.07%
+88,089
New +$4.88M
RVMD icon
281
Revolution Medicines
RVMD
$38.8B
$4.32M 0.07%
+219,197
New +$4.82M
YMAB
282
DELISTED
Y-mAbs Therapeutics
YMAB
$4.29M 0.06%
+297,252
New +$4.92M
RGP icon
283
Resources Connection
RGP
$153M
$4.25M 0.06%
+235,235
New +$4.72M
FSLR icon
284
First Solar
FSLR
$25B
$3.99M 0.06%
+30,170
New +$3.23M
AEHR icon
285
Aehr Test Systems
AEHR
$2.99B
$3.96M 0.06%
+281,191
New +$3.78M
SONX
286
DELISTED
Sonendo, Inc.
SONX
$3.94M 0.06%
+3,684,210
New +$5.36M
PINS icon
287
Pinterest
PINS
$13.5B
$3.94M 0.06%
+169,070
New +$3.71M
BLU
288
DELISTED
BELLUS Health Inc.
BLU
$3.92M 0.06%
+371,100
New +$3.94M
BMEA icon
289
Biomea Fusion
BMEA
$86.8M
$3.83M 0.06%
391,307
-10,105
-3% -$116K
FLL icon
290
Full House Resorts
FLL
$83M
$3.72M 0.06%
661,591
-311,261
-32% -$2.01M
JAKK icon
291
Jakks Pacific
JAKK
$298M
$3.61M 0.05%
+186,905
New +$3.84M
MORF
292
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.45M 0.05%
121,793
-3,115
-2% -$86.8K
ZWRK
293
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
$2.96M 0.04%
300,000
– –
FHTX icon
294
Foghorn Therapeutics
FHTX
$271M
$2.83M 0.04%
330,051
-52,889
-14% -$681K
GSAT icon
295
Globalstar
GSAT
$10.8B
$2.78M 0.04%
+116,520
New +$2.81M
ATHM icon
296
Autohome
ATHM
$2.68B
$2.77M 0.04%
96,322
-108,488
-53% -$3.78M
OVID icon
297
Ovid Therapeutics
OVID
$435M
$2.63M 0.04%
1,430,268
+86,943
+6% +$182K
PENG
298
Penguin Solutions Inc
PENG
$2.7B
$2.56M 0.04%
161,547
-226,118
-58% -$4.12M
RDY icon
299
Dr. Reddy's Laboratories
RDY
$10.1B
$2.41M 0.04%
+230,525
New +$2.46M
EMBJ
300
Embraer S.A. ADS
EMBJ
$12.6B
$2.41M 0.04%
+280,160
New +$2.78M
10 11
12
13 14

Similar funds

CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $13.5B AUM 15.15% 1-Year Est. Return
WA
Waverly Advisors Birmingham, Alabama $13.4B AUM 18.56% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Driehaus Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Driehaus Capital Management held 434 positions worth $6.6B, up 7% from $6.17B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Driehaus Capital Management's Q3 2022 filing shows 82 new, 115 increased, 129 reduced and 91 closed positions. Its largest new stake was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M. The largest sale was Pfizer, an estimated $75.3M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Driehaus Capital Management's largest Q3 2022 buy was Axonics, Inc. Common Stock: 648,976 shares worth $45.7M.
  • Driehaus Capital Management added most to Calix in Q3 2022, an estimated $48.2M increase.
  • Driehaus Capital Management's biggest Q3 2022 reduction was HDFC Bank, cutting an estimated $30M.
  • Driehaus Capital Management fully exited Pfizer in Q3 2022, selling an estimated $75.3M.
  • Driehaus Capital Management's ten largest holdings make up 18% of its $6.6B portfolio in Q3 2022.
  • Driehaus Capital Management opened 82 new positions and closed 91 in Q3 2022.
  • Driehaus Capital Management's portfolio value rose 7% quarter-over-quarter to $6.6B.

Based on Driehaus Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.